Outcomes of Veno Arterial ECMO
ECMOCARD
In-hospital Mortality of Patients With Veno Arterial ECMO: a Prospective Observational Study
1 other identifier
observational
150
1 country
1
Brief Summary
veno arterial (VA) extra corporeal membrane oxygenation (ECMO) is a rescue therapy with various indications including refractory cardiac arrest and refractory cardiogenic shock. Amiens hospital university has an ECMO program and is a regional center to address patients requiring VA ECMO. In spite of the application of international guidelines, the mortality of patients with VA remains high with an admitted survival rate at hospital discharge at 40%.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 16, 2021
CompletedStudy Start
First participant enrolled
November 16, 2021
CompletedFirst Posted
Study publicly available on registry
December 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
February 8, 2023
February 1, 2023
5 years
November 16, 2021
February 7, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
In-hospital mortality
In-hospital mortality of patients with : veno arterial (VA) extra corporeal membrane oxygenation (ECMO)
Up to hospital discharge, an average of 1 month
Eligibility Criteria
Patients admitted in Amiens hospital university beneficing of a veno arterial (VA) extra corporeal membrane oxygenation (ECMO).
You may qualify if:
- age : ≥ 18
- Patient with a VA ECMO
You may not qualify if:
- age\<18
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Amiens Picardie
Amiens, France
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 16, 2021
First Posted
December 14, 2021
Study Start
November 16, 2021
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
February 8, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share